Search

Author/Creator Brown, Michelle L

1. 1230. Clinical and Microbiologic Outcomes by Causative Pathogen in Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Treated with Imipenem/Cilastatin (IMI)/Relebactam (REL) Versus Piperacillin/Tazobactam (PIP/TAZ). (31st December 2020)

Authors:
Losada, Maria C; Maniar, Alok; Du, Jiejun; Brown, Michelle L; Young, Katherine; Hilbert, David W; Tipping, Robert; DeRyke, C Andrew; Butterton, Joan R; Paschke, Amanda; Chen, Luke F
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S635
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1460. Imipenem/Cilastatin (IMI)/Relebactam (REL) in Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia (HABP/VABP): Subgroup Analyses of Critically Ill Patients in the RESTORE-IMI 2 Trial. (31st December 2020)

Authors:
Chen, Luke F; Losada, Maria C; Mahoney, Kathryn A; Du, Jiejun; Brown, Michelle L; Tipping, Robert; Young, Katherine; DeRyke, C Andrew; Butterton, Joan R; Paschke, Amanda
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S732
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 1574. Multivariate Regression Analysis to Determine Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Trial. (31st December 2020)

Authors:
Tipping, Robert; Du, Jiejun; Losada, Maria C; Brown, Michelle L; Young, Katherine; Butterton, Joan R; Paschke, Amanda; Chen, Luke F
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S785
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study). (12th August 2020)

Authors:
Titov, Ivan; Wunderink, Richard G; Roquilly, Antoine; Rodríguez Gonzalez, Daniel; David-Wang, Aileen; Boucher, Helen W; Kaye, Keith S; Losada, Maria C; Du, Jiejun; Tipping, Robert; Rizk, Matthew L; Patel, Munjal; Brown, Michelle L; Young, Katherine; Kartsonis, Nicholas A; Butterton, Joan R; Pasch...
Journal:
Clinical infectious diseases
Issue:
Volume 73:Number 11(2021)
Page Start:
e4539
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study. (19th February 2020)

Authors:
Brown, Michelle L; Motsch, Johann; Kaye, Keith S; File, Thomas M; Boucher, Helen W; Vendetti, Neika; Aggrey, Angela; Joeng, Hee-Koung; Tipping, Robert W; Du, Jiejun; DePestel, Daryl D; Butterton, Joan R; Paschke, Amanda
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 3(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections. (10th August 2019)

Authors:
Motsch, Johann; Murta de Oliveira, Cláudia; Stus, Viktor; Köksal, Iftihar; Lyulko, Olexiy; Boucher, Helen W; Kaye, Keith S; File, Thomas M; Brown, Michelle L; Khan, Ireen; Du, Jiejun; Joeng, Hee-Koung; Tipping, Robert W; Aggrey, Angela; Young, Katherine; Kartsonis, Nicholas A; Butterton, Joan R; ...
Journal:
Clinical infectious diseases
Issue:
Volume 70:Number 9(2020)
Page Start:
1799
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗